Diseases, Conditions, Syndromes

FDA approves mavyret for children, adolescents with hep C

(HealthDay)—Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17 years, the U.S. Food and Drug Administration announced yesterday.

Diseases, Conditions, Syndromes

High response seen for all Hep C Tx models in injection drug users

(HealthDay)—For people with hepatitis C virus (HCV) who inject drugs (PWID) and receive opioid agonist therapy (OAT), receipt of HCV treatment is associated with high sustained virologic response (SVR), according to a study ...

Diseases, Conditions, Syndromes

Slight decline in hepatitis C diagnoses in Europe

European surveillance data show a 10 percent decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31,000 recorded cases in 2017, diagnoses remain at a high level in the European Union ...

Diseases, Conditions, Syndromes

Appalachia, western states have highest hepatitis C prevalence

(HealthDay)—States in the West and in Appalachia have a higher prevalence of hepatitis C virus (HCV) infection than other states, according to a study published online Dec. 21 in JAMA Network Open.

page 8 from 30